Search Results for: Atox Bio

By Jewish Business News On Monday, December 4th, 2017

Israeli clinical stage Atox Bio Closes $30 Million Investment

Atox Bio, a clinical stage biotechnology company developing novel immunomodulators for critically ill patients, has raised $30 million. The round was led by Arix Bioscience plc with participation from Adams Street More...

By Jewish Business News On Thursday, July 24th, 2014

Infections treatment co Atox Bio raises $23 million

– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has raised up to $23 million in a Series E investment led More...

By Gil Tanenbaum On Tuesday, September 30th, 2014

Altox Bio Gets $24 Million to Fight Flesh Eating Disease

Atox Bio, an Israeli a clinical stage biotechnology company, has been awarded a $24 million contract to fight flesh eating diseases. No, such diseases are not something out of the Walking Dead which could More...

By Michael Ordman On Sunday, October 5th, 2014

Robotic Heart Surgery in Action and Much More Good news from Israel

A new way to fight infection.  The US Biomedical R&D Authority has awarded Israel’s Atox Bio $24 million to develop its treatments for severe infections.  Atox Bio’s AB103 uniquely modulates the patient’s More...

By Vered Weiss On Wednesday, July 30th, 2014

Israeli Hi-Tech Businesses Continue to Thrive During War

– The conflict between Israel and Hamas is not causing Israeli businesses to hide out in the trenches. Rocket fire and negative media coverage do not seem to be effective weapons against business and technology. More...

Wordpress site Developed by Fixing WordPress Problems